Oruka Therapeutics Inc (ORKA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,826 | -1,346 | -9,926 | -8,752 | -6,419 |
| Depreciation Amortization | 58 | 29 | 114 | 85 | 57 |
| Accounts payable and accrued liabilities | -93 | 32 | -783 | -524 | -7 |
| Other Working Capital | 88 | -482 | -1,661 | -1,192 | -899 |
| Other Operating Activity | 484 | 172 | 1,344 | 965 | 348 |
| Operating Cash Flow | $-2,289 | $-1,595 | $-10,912 | $-9,418 | $-6,920 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -2 | -2 | -2 |
| Investing Cash Flow | $N/A | $N/A | $-2 | $-2 | $-2 |
| Cash Flows From Financing Activities | |||||
| Financing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Beginning Cash Position | 42,445 | 42,445 | 53,359 | 53,359 | 53,359 |
| End Cash Position | 40,156 | 40,850 | 42,445 | 43,939 | 46,437 |
| Net Cash Flow | $-2,289 | $-1,595 | $-10,914 | $-9,420 | $-6,922 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,289 | -1,595 | -10,912 | -9,418 | -6,920 |
| Capital Expenditure | N/A | N/A | -2 | -2 | -2 |
| Free Cash Flow | -2,289 | -1,595 | -10,914 | -9,420 | -6,922 |